What is Driving the Growth of the Renal Biomarkers Market?
The renal biomarkers market is gaining rapid traction due to the increasing global burden of kidney diseases and the urgent need for early diagnosis tools. In 2024, the market was valued at USD 970.40 million, and it is projected to expand at a CAGR of 7.65% from 2025 to 2034, reaching a valuation of USD 2028.11 million by 2034. Chronic kidney disease (CKD) and acute kidney injury (AKI) are...
0 Commentaires 0 Parts 623 Vue 0 Aperçu